118 related articles for article (PubMed ID: 8544903)
1. Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe.
Klunk WE; Debnath ML; Pettegrew JW
Neurobiol Aging; 1995; 16(4):541-8. PubMed ID: 8544903
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease.
Dezutter NA; Dom RJ; de Groot TJ; Bormans GM; Verbruggen AM
Eur J Nucl Med; 1999 Nov; 26(11):1392-9. PubMed ID: 10552079
[TBL] [Abstract][Full Text] [Related]
3. Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease.
Klunk WE; Debnath ML; Pettegrew JW
Neurobiol Aging; 1994; 15(6):691-8. PubMed ID: 7891823
[TBL] [Abstract][Full Text] [Related]
4. Amyloid binding ligands as Alzheimer's disease therapies.
Lee VM
Neurobiol Aging; 2002; 23(6):1039-42. PubMed ID: 12470800
[TBL] [Abstract][Full Text] [Related]
5. Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer's brain.
Mutsuga M; Chambers JK; Uchida K; Tei M; Makibuchi T; Mizorogi T; Takashima A; Nakayama H
J Vet Med Sci; 2012 Jan; 74(1):51-7. PubMed ID: 21891973
[TBL] [Abstract][Full Text] [Related]
6. Binding of proteases to fibrillar amyloid-beta protein and its inhibition by Congo red.
Chander H; Chauhan A; Chauhan V
J Alzheimers Dis; 2007 Nov; 12(3):261-9. PubMed ID: 18057560
[TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
[TBL] [Abstract][Full Text] [Related]
8. The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.
Klunk WE; Wang Y; Huang GF; Debnath ML; Holt DP; Shao L; Hamilton RL; Ikonomovic MD; DeKosky ST; Mathis CA
J Neurosci; 2003 Mar; 23(6):2086-92. PubMed ID: 12657667
[TBL] [Abstract][Full Text] [Related]
9. Chrysamine-G, a lipophilic analogue of Congo red, inhibits A beta-induced toxicity in PC12 cells.
Klunk WE; Debnath ML; Koros AM; Pettegrew JW
Life Sci; 1998; 63(20):1807-14. PubMed ID: 9820124
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
11. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
12. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
[TBL] [Abstract][Full Text] [Related]
14. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
15. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.
Styren SD; Hamilton RL; Styren GC; Klunk WE
J Histochem Cytochem; 2000 Sep; 48(9):1223-32. PubMed ID: 10950879
[TBL] [Abstract][Full Text] [Related]
16. A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls.
Savioz A; Giannakopoulos P; Herrmann FR; Klein WL; Kövari E; Bouras C; Giacobini E
Neurodegener Dis; 2016; 16(5-6):398-406. PubMed ID: 27400224
[TBL] [Abstract][Full Text] [Related]
17. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
18. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
Armstrong RA
Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
[TBL] [Abstract][Full Text] [Related]
19. Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain.
Mathis CA; Wang Y; Klunk WE
Curr Pharm Des; 2004; 10(13):1469-92. PubMed ID: 15134570
[TBL] [Abstract][Full Text] [Related]
20. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
